646
Views
0
CrossRef citations to date
0
Altmetric
Original Article

Postnatal weight gain and retinopathy of prematurity in preterm infants: a population-based retrospective cohort study

, , ORCID Icon, &
Article: 2337720 | Received 08 Sep 2023, Accepted 27 Mar 2024, Published online: 14 Apr 2024

References

  • Kim SJ, Port AD, Swan R, et al. Retinopathy of prematurity: a review of risk factors and their clinical significance. Surv Ophthalmol. 2018;63(5):1–12. doi:10.1016/j.survophthal.2018.04.002.
  • Mintz-Hittner HA, Kennedy KA, Chuang AZ. Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity. N Engl J Med. 2011;364(7):603–615. doi:10.1056/NEJMoa1007374.
  • Chan-Ling T, Gole GA, Quinn GE, et al. Pathophysiology, screening and treatment of ROP: a multi-disciplinary perspective. Prog Retin Eye Res. 2018;62:77–119. doi:10.1016/j.preteyeres.2017.09.002.
  • Ashton N, Ward B, Serpell G. Effect of oxygen on developing retinal vessels with particular reference to the problem of retrolental fibroplasia. Br J Ophthalmol. 1954;38(7):397–432. doi:10.1136/bjo.38.7.397.
  • Fierson WM, American Academy of Pediatrics Section on Ophthalmology; American Academy of Ophthalmology, et al. Screening examination of premature infants for retinopathy of prematurity. Pediatrics. 2013;131(1):189–195. doi:10.1542/peds.2012-2996.
  • Martin JA, Hamilton BE, Osterman MJ, et al. Births: final data for 2015. Natl Vital Stat Rep. 2017;66(1):1.
  • Chiang MF, Arons RR, Flynn JT, et al. Incidence of retinopathy of prematurity from 1996 to 2000: analysis of a comprehensive New York state patient database. Ophthalmology. 2004;111(7):1317–1325. doi:10.1016/j.ophtha.2003.10.030.
  • Gerull R, Brauer V, Bassler D, et al. Incidence of retinopathy of prematurity (ROP) and ROP treatment in Switzerland 2006–2015: a population-based analysis. Arch Dis Child Fetal Neonatal Ed. 2018;103(4):F337–F342. doi:10.1136/archdischild-2017-313574.
  • Mitchell AJ, Green A, Jeffs DA, et al. Physiologic effects of retinopathy of prematurity screening examinations. Adv Neonatal Care. 2011;11(4):291–297. doi:10.1097/ANC.0b013e318225a332.
  • Kemper AR, Wallace DK. Neonatologists’ practices and experiences in arranging retinopathy of prematurity screening services. Pediatrics. 2007;120(3):527–531. doi:10.1542/peds.2007-0378.
  • Hutchinson AK, Melia M, Yang MB, et al. Clinical models and algorithms for the prediction of retinopathy of prematurity: a report by the American academy of ophthalmology. Ophthalmology. 2016;123(4):804–816. doi:10.1016/j.ophtha.2015.11.003.
  • Hellström A, Hård AL, Engström E, et al. Early weight gain predicts retinopathy in preterm infants: new, simple, efficient approach to screening. Pediatrics. 2009;123(4):e638–e645. doi:10.1542/peds.2008-2697.
  • Jensen AK, Ying GS, Huang J, et al. Postnatal serum insulin-like growth factor I and retinopathy of prematurity. Retina. 2017;37(5):867–872. doi:10.1097/IAE.0000000000001247.
  • Cakir B, Hellström W, Tomita Y, et al. IGF1, serum glucose, and retinopathy of prematurity in extremely preterm infants. JCI Insight. 2020;5(19):e140363. doi:10.1172/jci.insight.140363.
  • Löfqvist C, Hansen-Pupp I, Andersson E, et al. Validation of a new retinopathy of prematurity screening method monitoring longitudinal postnatal weight and insulin-like growth factor I. Arch Ophthalmol. 2009;127(5):622–627. doi:10.1001/archophthalmol.2009.69.
  • Wu C, Löfqvist C, Smith LE, et al. Importance of early postnatal weight gain for normal retinal angiogenesis in very preterm infants: a multicenter study analyzing weight velocity deviations for the prediction of retinopathy of prematurity. Arch Ophthalmol. 2012;130(8):992–999. doi:10.1001/archophthalmol.2012.243.
  • Ko CH, Kuo HK, Chen CC, et al. Using WINROP as an adjuvant screening tool for retinopathy of prematurity in Southern Taiwan. Am J Perinatol. 2015;30(2):149–154. doi:10.1055/s-0034-1376389.
  • Binenbaum G, Bell EF, Donohue P, et al. Development of modified screening criteria for retinopathy of prematurity: primary results from the postnatal growth and retinopathy of prematurity study. JAMA Ophthalmol. 2018;136(9):1034–1040. doi:10.1001/jamaophthalmol.2018.2753.
  • Yabas Kiziloglu O, Coskun Y, Akman I. Assessment of the G-ROP study criteria for predicting retinopathy of prematurity: results from a tertiary Centre in Turkey. Int Ophthalmol. 2020;40(7):1647–1652. doi:10.1007/s10792-020-01332-5.
  • Anuk İnce D, Gülcan H, Hanta D, et al. Poor postnatal weight gain predicts stage 3 + retinopathy of prematurity in very low birth weight infants. Turk J Pediatr. 2013;55:304–308.
  • Aydemir O, Sarikabadayi YU, Aydemir C, et al. Adjusted poor weight gain for birth weight and gestational age as a predictor of severe ROP in VLBW infants. Eye (Lond). 2011;25(6):725–729. doi:10.1038/eye.2011.29.
  • A Joint Statement of the American Academy of Pediatric, the American Association for Pediatric Ophthalmology and Strabismus, and the American Academy of Ophthalmology. Screening examination of premature infants for retinopathy of prematurity. Ophthalmology. 1997;104:888–889.
  • Fierson WM; American Academy of Pediatrics Section on Ophthalmology; American Academy of Ophthalmology; American Association for Pediatric Ophthalmology and Strabismus; American Association of Certified Orthoptists. Screening Examination of Premature Infants for Retinopathy of Prematurity. Pediatrics. 2018;142(6):e20183061. Pediatrics. 2019;143:e20183810. doi:10.1542/peds.2018-3810.
  • Wallace DK, Kylstra JA, Phillips SJ, et al. Poor postnatal weight gain: a risk factor for severe retinopathy of prematurity. J Aapos. 2000;4(6):343–347. doi:10.1067/mpa.2000.110342.
  • Cabañas Poy MJ, Montoro Ronsano JB, Castillo Salinas F, et al. Association between postnatal weight gain and need for treatment in retinopathy of prematurity. J Matern Fetal Neonatal Med. 2022;35(25):8027–8031. doi:10.1080/14767058.2021.1940937.
  • Bas AY, Demirel N, Koc E, et al. Incidence, risk factors and severity of retinopathy of prematurity in Turkey (TR-ROP study): a prospective, multicentre study in 69 neonatal intensive care units. Br J Ophthalmol. 2018;102(12):1711–1716. doi:10.1136/bjophthalmol-2017-311789.
  • Rao KA, Purkayastha J, Hazarika M, et al. Analysis of prenatal and postnatal risk factors of retinopathy of prematurity in a tertiary care hospital in South India. Indian J Ophthalmol. 2013;61(11):640–644. doi:10.4103/0301-4738.119347.
  • Lundgren P, Hård AL, Wilde Å, et al. Implementing higher oxygen saturation targets reduced the impact of poor weight gain as a predictor for retinopathy of prematurity. Acta Paediatr. 2018;107(5):767–773. doi:10.1111/apa.14049.
  • Sun Y, Hellström A, Smith Lois, E, H. Retinopathy of prematurity. In: Martin RJ, Fanaroff AA, Walsh MC, editors. Fanaroff and Martin’s neonatal-perinatal medicine-diseases of the fetus and newborn. 10th ed. Philadelphia (PA): Saunders Elsevier. 2015;1767–1774.
  • Alajbegovic-Halimic J, Zvizdic D, Alimanovic-Halilovic E, et al. Risk factors for retinopathy of prematurity in premature born children. Med Arch. 2015;69(6):409–413. doi:10.5455/medarh.2015.69.409-413.
  • Ali AA, Gomaa NAS, Awadein AR, et al. Retrospective cohort study shows that the risks for retinopathy of prematurity included birth age and weight, medical conditions and treatment. Acta Paediatr. 2017;106(12):1919–1927. doi:10.1111/apa.14019.
  • Schaffer DB, Palmer EA, Plotsky DF, et al. Prognostic factors in the natural course of retinopathy of prematurity. The Cryotherapy for Retinopathy of Prematurity Cooperative Group. Ophthalmology. 1993;100(2):230–237. doi:10.1016/s0161-6420(93)31665-9.
  • Yim CL, Tam M, Chan HL, et al. Association of antenatal steroid and risk of retinopathy of prematurity: a systematic review and meta-analysis. Br J Ophthalmol. 2018;102(10):1336–1341. doi:10.1136/bjophthalmol-2017-311576.
  • Eriksson L, Haglund B, Ewald U, et al. Short and long-term effects of antenatal corticosteroids assessed in a cohort of 7,827 children born preterm. Acta Obstet Gynecol Scand. 2009;88(8):933–938. doi:10.1080/00016340903111542.
  • Maini B, Chellani H, Arya S, et al. Retinopathy of prematurity: risk factors and role of antenatal betamethasone in Indian preterm newborn babies. J Clin Neonatol. 2014;3(1):20–24. doi:10.4103/2249-4847.128724.
  • Movsas TZ, Spitzer AR, Gewolb IH. Postnatal corticosteroids and risk of retinopathy of prematurity. J AAPOS. 2016;20(4):348–352. doi:10.1016/j.jaapos.2016.05.008.
  • Fundora JB, Binenbaum G, Tomlinson L, et al. Association of surgical necrotizing enterocolitis and its timing with retinopathy of prematurity. Am J Perinatol. 2023;40(11):1178–1184. doi:10.1055/s-0041-1733785.
  • Silva JF, Ocarino NM, Vieira AL, et al. Effects of hypo- and hyperthyroidism on proliferation, angiogenesis, apoptosis and expression of COX-2 in the corpus luteum of female rats. Reprod Domest Anim. 2013;48(4):691–698. doi:10.1111/rda.12149.
  • Coşkun Y, Kızıloğlu ÖY, Bayram T, et al. Thyroid hormones have any effects on the development of retinopathy of prematurity? Haydarpasa Numune Med J. 2019;60:60–66. doi:10.14744/hnhj27122.
  • Korkmaz L, Baştuğ O, Daar G, et al. The effects of thyroid function on retinopathy of prematurity. J Neonatal Perinatal Med. 2016;9(4):349–356. doi:10.3233/NPM-915150.
  • Hays SP, Smith EO, Sunehag AL. Hyperglycemia is a risk factor for early death and morbidity in extremely low birth-weight infants. Pediatrics. 2006;118(5):1811–1818. doi:10.1542/peds.2006-0628.
  • Leung M, Black J, Bloomfield FH, et al. Effects of neonatal hyperglycemia on retinopathy of prematurity and visual outcomes at 7 years of age: a matched cohort study. J Pediatr. 2020;223:42–50.e2. doi:10.1016/j.jpeds.2020.04.059.
  • Choręziak A, Szpecht D, Chmielarz-Czarnocińska A, et al. The association of platelet counts with development and treatment for retinopathy of prematurity – is thrombocytopenia a risk factor? Arch Med Sci. 2022;18(2):400–405. doi:10.5114/aoms.2019.85386.
  • Vinekar A, Hegde K, Gilbert C, et al. Do platelets have a role in the pathogenesis of aggressive posterior retinopathy of prematurity? Retina. 2010;30(4 Suppl):S20–S23. doi:10.1097/IAE.0b013e3181cafc30.
  • Kirpalani H, Whyte RK, Andersen C, et al. The Premature Infants in Need of Transfusion (PINT) study: a randomized, controlled trial of a restrictive (low) versus liberal (high) transfusion threshold for extremely low birth weight infants. J Pediatr. 2006;149(3):301–307. doi:10.1016/j.jpeds.2006.05.011.
  • Beken S, Dilli D, Fettah ND, et al. The influence of fish-oil lipid emulsions on retinopathy of prematurity in very low birth weight infants: a randomized controlled trial. Early Hum Dev. 2014;90(1):27–31. doi:10.1016/j.earlhumdev.2013.11.002.